Regional Collaboration AJ Vaccines is actively engaging with regional partners including RegionH Hvidovre Hospital, Nuvonis, Statens Serum Institute, and the University of Copenhagen, suggesting opportunities to offer complementary diagnostics, therapeutic solutions, or contract manufacturing services aligned with public health initiatives and regional vaccine programs.

Expansion Momentum The company has invested in production facilities and staffing to scale operations, indicating potential for supply agreements, contract manufacturing, and technology transfer opportunities as they expand manufacturing capacity and diversify vaccine portfolios.

Polio and Adjuvant Expertise Recent WHO prequalification of an inactivated polio vaccine and history of adjuvant IPV development position AJ Vaccines as a partner for manufacturers seeking polio vaccine production, adjuvant formulation, and global access programs.

COVID-19 Capability Ongoing involvement in COVID-19 vaccine development programs demonstrates readiness to collaborate on viral vaccine candidates, clinical development partnerships, or manufacturing support for emerging respiratory pathogens.

Danish Innovation Hub Headquartered in Copenhagen with a diverse multinational team, AJ Vaccines presents a strategic entry point for Europe-based partnerships in vaccine R&D, diagnostics, and therapeutic solutions, including potential co-development and regional distribution deals.